REGENXBIO Inc. — Director's Dealing 2015

Sep 22, 2015

SEC Form 4/A — Form 4/A

Issuer: REGENXBIO Inc. (RGNX)
CIK: 0001590877
Period of Report: 2015-09-16

Reporting Person: HAYDEN DONALD J JR (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-09-16	Stock Option (Right to Buy)	$22.00	A	9375	Acquired	2025-09-16	Common Stock (9375)	Direct

Footnotes

F1: The Number of Derivative Securities Acquired, the Amount of Underlying Securities and the Number of Derivative Securities Beneficially Owned Following Reported Transaction were inadvertently misreported by the Reporting Person on the Form 4 file on September 17, 2015.

F2: The option will vest in equal monthly installments over the 12 months following September 16, 2015, with immediate full vesting in the event of a change in control.